COMBINATION CHEMOTHERAPY WITH VINCRISTINE SULFATE (VCR), CYCLOPHOSPHAMIDE (CTX), AND ACTINOMYCIN-D (ACT-D) IN CHILDREN WITH MALIGNANT OVARIAN TUMORS

被引：0
|
作者：
CANGIR, A [1 ]
SMITH, J [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1977年 / 18卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [41] Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
    Turan, T
    Karacay, O
    Tulunay, G
    Boran, N
    Koc, S
    Bozok, S
    Kose, MF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1432 - 1438
  • [42] Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies
    Fuchimoto, Yasushi
    Morikawa, Nobuyuki
    Kuroda, Tatsuo
    Hirobe, Seiichi
    Kamagata, Shouichiro
    Kumagai, Masaaki
    Matsuoka, Kentaro
    Morikawa, Yasuhide
    PEDIATRICS INTERNATIONAL, 2012, 54 (02) : 285 - 287
  • [43] Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide
    Choi, Aery
    Kang, Young Kyung
    Lim, Sewon
    Kim, Dong Ho
    Lim, Jung Sub
    Lee, Jun Ah
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1443 - 1447
  • [44] VINBLASTINE, ACTINOMYCIN-D, BLEOMYCIN, CYCLOPHOSPHAMIDE AND CIS-PLATINUM COMBINATION CHEMOTHERAPY IN METASTATIC TESTIS CANCER - A 1-YEAR PROGRAM
    VUGRIN, D
    WHITMORE, WF
    GOLBEY, RB
    JOURNAL OF UROLOGY, 1982, 128 (06): : 1205 - 1208
  • [45] COMBINATION OF IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE ACTINOMYCIN-D CHEMOTHERAPY POTENTIATES ANTILEUKEMIC EFFECT AND REDUCES TOXICITY IN A L1210 LEUKEMIA MODEL IN MICE
    LASEK, W
    SORA, M
    WANKOWICZ, A
    JAKOBISIAK, M
    CANCER LETTERS, 1995, 89 (01) : 137 - 143
  • [46] MALIGNANT LYMPHOMA INVOLVING THE JAW IN AFRICAN CHILDREN - TREATMENT WITH ALKYLATING AGENTS AND ACTINOMYCIN-D
    OETTGEN, HF
    CLIFFORD, P
    BURKITT, D
    CANCER CHEMOTHERAPY REPORTS, 1963, (28): : 25 - 34
  • [47] IMPROVED PROGNOSIS IN CHILDREN WITH OVARIAN CANCERS FOLLOWING MODIFIED VAC (VINCRISTINE SULFATE, DACTINOMYCIN, AND CYCLOPHOSPHAMIDE) CHEMOTHERAPY
    CANGIR, A
    SMITH, J
    EYS, JV
    CANCER, 1978, 42 (03) : 1234 - 1238
  • [48] FIVE DAYS INTRAVASCULAR (IV) METHOTREXATE VERSUS BIWEEKLY ACTINOMYCIN-D(ACT-D) IN TREATMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA: A RANDOMIZED CLINICAL TRIAL
    Fariba, Y.
    Adabi, K.
    Haghi, S.
    Haghi, Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 659 - 659
  • [49] Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy
    Escobar, PF
    Lurain, JR
    Singh, DK
    Bozorgi, K
    Fishman, DA
    GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 552 - 557
  • [50] Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis
    Kojima, Yuki
    Hashimoto, Kenji
    Ando, Masashi
    Yonemori, Kan
    Yamamoto, Harukaze
    Kodaira, Makoto
    Yunokawa, Mayu
    Shimizu, Chikako
    Tamura, Kenji
    Hosono, Ako
    Makimoto, Atsushi
    Fujiwara, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 391 - 397
12345